Amnova Biotech

1 known investors

Amnova Biotech is developing a first-in-class injectable regenerative biomaterial therapy designed to repair heart tissue after myocardial infarction. The treatment is delivered directly into damaged cardiac tissue during existing clinical procedures to restore function and limit long-term damage.

BiotechHealthtechMedical Devices